SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Chia KS, Lee HP, Seow A, Shanmugaratnam K. Trends in cancer incidence in Singapore 1968–1992. Singapore Cancer Registry Report no. 4, Singapore, 1995.
  • 2
    Chia KS, Seow A, Lee HP, Shanmugaratnam K. Cancer incidence in Singapore 1993–1997. Singapore Cancer Registry Report no. 5, Singapore, 2000.
  • 3
    Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38: 93342.
  • 4
    Voutilanen ET, Dickman PW, Hakulinen T. SURV2: relative survival analysis program, version 2.02, Helsinki, Finish Cancer Registry, 1998.
  • 5
    Registrar-General of Births and Deaths. Report on registration of births and deaths, 1968 to 1992, Republic of Singapore.
  • 6
    Department of Statistics. Yearbook of statistics, 1968 to 1992. Republic of Singapore.
  • 7
    Sankaranarayanan R, Black RJ, Swaminathan R, Parkin DM. An overview of cancer survival in developing countries. In: SankaranarayananR, BlackRJ, ParkinDM, editors. Cancer survival in developing countries. IARC Scientific Publication no. 145. Lyon: International Agency for Research on Cancer, 1998. p 13573.
  • 8
    SankaranarayananR, BlackRJ, ParkinDM (eds). Cancer survival in developing countries. IARC Scientific Publication no. 145. Lyon: International Agency for Research on Cancer, 1998.
  • 9
    Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J. Survival of cancer patients in Europe: the EUROCARE Study. IARC Scientific Publication no. 132. Lyon: International Agency for Research on Cancer, 1995.
  • 10
    Berrino F, Capocaccia R, Esteve J, et al. Survival of cancer patients in Europe: the EUROCARE-2 Study. IARC Scientific Publication no. 151. Lyon: International Agency for Research on Cancer, 1999.
  • 11
    Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK. SEER cancer statistics review, 1973–1994. National Cancer Institute. NIH Publication no. 97-2789. Bethesda, MD: NIH, 1997.
  • 12
    Osaka Cancer Registry. Survival of cancer patients in Osaka, 1975–89. Osaka Cancer Registry, Japan, 1998.
  • 13
    Black RJ, Sankaranarayanan R., Parkin DM. Interpretation of population-based cancer survival data. In: Sankaranarayanan, R, BlackRJ, D.M.Parkin DM, editors. Cancer survival in developing countries. IARC Scientific Publication no. 145. Lyon: International Agency for Research on Cancer, 1998.
  • 14
    Lim MK. 1998. Health care systems in transition II. Singapore, Part I: An overview of health care systems in Singapore. J Public Health Med 1998;20: 1622.
  • 15
    Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds). Cancer incidence in five continents, vol VII. IARC Scientific Publication no. 143. Lyon: International Agency for Research on Cancer, 1998.
  • 16
    PercyC, Van HoltenV, MuirC, editors. International classification of diseases for oncology 2nd ed. Geneva: World Health Organization, 1990.
  • 17
    Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336: 18559.